Natriuretic Peptide Market 2027 By Product Type, End users/Applications | The Insight Partners

Natriuretic Peptide Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (0.1-1000 pg/Ml, 0.31-20 ng/Ml); End users/Applications (Medical Care, Others)

Report Code: TIPRE00011114 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Natriuretic peptides, or brain natriuretic peptide, is a 32-amino acid (AA) polypeptide, that is produced by ventricles of the heart, as a reflex action to over-stretching of cardiac muscles cells. Calcium ions control the generation of BNP. BNP and ANP (atrial natriuretic peptide) are working similarly, and the physiological action of both is similar. The important function of ANP and BNP is to decrease the systemic vascular resistance, which leads to a decrease in blood volume, thus results in a reduction of blood pressure and an increase in cardiac output.

MARKET DYNAMICS

The natriuretic peptide market is driving due to the increased prevalence of cardiac diseases, rise in awareness about healthcare and diagnostic technology, sophisticated nature of test. However, lack of accuracy and lack of awareness are the major restraints of the growth of market.

MARKET SCOPE

The "Natriuretic Peptide Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of natriuretic peptide market with detailed market segmentation by product type and application. The natriuretic peptide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in natriuretic peptide market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The natriuretic peptide market is segmented on the basis of product type and application. Based on product type, the market is segmented as 0.1-1000 pg/Ml an0.31-20 ng/Ml. On the basis of end user/application, the market is categorized as medical care and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the natriuretic peptide market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The natriuretic peptide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting natriuretic peptide market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the natriuretic peptide market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the natriuretic peptide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from natriuretic peptide market are anticipated to have lucrative growth opportunities in the future with the rising demand for natriuretic peptide in the global market. Below mentioned is the list of few companies engaged in the natriuretic peptide market.

The report also includes the profiles of key players in natriuretic peptide market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Abbott Diagnostics
  •   AssayPro
  •   Aviva Systems Biology
  •   Beckman Coulter Inc.
  •   Biomatik
  •   Bio-Rad Laboratories, Inc.
  •   Novus Biologicals
  •   Raybiotech
  •   Roche Diagnostics
  •   WebMD LLC


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Natriuretic Peptide Market - By Product Type
1.3.2 Natriuretic Peptide Market - By End users/Applications
1.3.3 Natriuretic Peptide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NATRIURETIC PEPTIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NATRIURETIC PEPTIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NATRIURETIC PEPTIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. NATRIURETIC PEPTIDE - GLOBAL MARKET OVERVIEW
6.2. NATRIURETIC PEPTIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NATRIURETIC PEPTIDE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. 0.1-1000 PG/ML
7.3.1. Overview
7.3.2. 0.1-1000 pg/Ml Market Forecast and Analysis
7.4. 0.31-20 NG/ML
7.4.1. Overview
7.4.2. 0.31-20 ng/Ml Market Forecast and Analysis
8. NATRIURETIC PEPTIDE MARKET - REVENUE AND FORECASTS TO 2027 - END USERS/APPLICATIONS
8.1. OVERVIEW
8.2. END USERS/APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. MEDICAL CARE
8.3.1. Overview
8.3.2. Medical Care Market Forecast and Analysis
8.4. OTHERS
8.4.1. Overview
8.4.2. Others Market Forecast and Analysis
9. NATRIURETIC PEPTIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Natriuretic Peptide Market Overview
9.1.2 North America Natriuretic Peptide Market Forecasts and Analysis
9.1.3 North America Natriuretic Peptide Market Forecasts and Analysis - By Product Type
9.1.4 North America Natriuretic Peptide Market Forecasts and Analysis - By End users/Applications
9.1.5 North America Natriuretic Peptide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Natriuretic Peptide Market
9.1.5.1.1 United States Natriuretic Peptide Market by Product Type
9.1.5.1.2 United States Natriuretic Peptide Market by End users/Applications
9.1.5.2 Canada Natriuretic Peptide Market
9.1.5.2.1 Canada Natriuretic Peptide Market by Product Type
9.1.5.2.2 Canada Natriuretic Peptide Market by End users/Applications
9.1.5.3 Mexico Natriuretic Peptide Market
9.1.5.3.1 Mexico Natriuretic Peptide Market by Product Type
9.1.5.3.2 Mexico Natriuretic Peptide Market by End users/Applications
9.2. EUROPE
9.2.1 Europe Natriuretic Peptide Market Overview
9.2.2 Europe Natriuretic Peptide Market Forecasts and Analysis
9.2.3 Europe Natriuretic Peptide Market Forecasts and Analysis - By Product Type
9.2.4 Europe Natriuretic Peptide Market Forecasts and Analysis - By End users/Applications
9.2.5 Europe Natriuretic Peptide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Natriuretic Peptide Market
9.2.5.1.1 Germany Natriuretic Peptide Market by Product Type
9.2.5.1.2 Germany Natriuretic Peptide Market by End users/Applications
9.2.5.2 France Natriuretic Peptide Market
9.2.5.2.1 France Natriuretic Peptide Market by Product Type
9.2.5.2.2 France Natriuretic Peptide Market by End users/Applications
9.2.5.3 Italy Natriuretic Peptide Market
9.2.5.3.1 Italy Natriuretic Peptide Market by Product Type
9.2.5.3.2 Italy Natriuretic Peptide Market by End users/Applications
9.2.5.4 Spain Natriuretic Peptide Market
9.2.5.4.1 Spain Natriuretic Peptide Market by Product Type
9.2.5.4.2 Spain Natriuretic Peptide Market by End users/Applications
9.2.5.5 United Kingdom Natriuretic Peptide Market
9.2.5.5.1 United Kingdom Natriuretic Peptide Market by Product Type
9.2.5.5.2 United Kingdom Natriuretic Peptide Market by End users/Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Natriuretic Peptide Market Overview
9.3.2 Asia-Pacific Natriuretic Peptide Market Forecasts and Analysis
9.3.3 Asia-Pacific Natriuretic Peptide Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Natriuretic Peptide Market Forecasts and Analysis - By End users/Applications
9.3.5 Asia-Pacific Natriuretic Peptide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Natriuretic Peptide Market
9.3.5.1.1 Australia Natriuretic Peptide Market by Product Type
9.3.5.1.2 Australia Natriuretic Peptide Market by End users/Applications
9.3.5.2 China Natriuretic Peptide Market
9.3.5.2.1 China Natriuretic Peptide Market by Product Type
9.3.5.2.2 China Natriuretic Peptide Market by End users/Applications
9.3.5.3 India Natriuretic Peptide Market
9.3.5.3.1 India Natriuretic Peptide Market by Product Type
9.3.5.3.2 India Natriuretic Peptide Market by End users/Applications
9.3.5.4 Japan Natriuretic Peptide Market
9.3.5.4.1 Japan Natriuretic Peptide Market by Product Type
9.3.5.4.2 Japan Natriuretic Peptide Market by End users/Applications
9.3.5.5 South Korea Natriuretic Peptide Market
9.3.5.5.1 South Korea Natriuretic Peptide Market by Product Type
9.3.5.5.2 South Korea Natriuretic Peptide Market by End users/Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Natriuretic Peptide Market Overview
9.4.2 Middle East and Africa Natriuretic Peptide Market Forecasts and Analysis
9.4.3 Middle East and Africa Natriuretic Peptide Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Natriuretic Peptide Market Forecasts and Analysis - By End users/Applications
9.4.5 Middle East and Africa Natriuretic Peptide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Natriuretic Peptide Market
9.4.5.1.1 South Africa Natriuretic Peptide Market by Product Type
9.4.5.1.2 South Africa Natriuretic Peptide Market by End users/Applications
9.4.5.2 Saudi Arabia Natriuretic Peptide Market
9.4.5.2.1 Saudi Arabia Natriuretic Peptide Market by Product Type
9.4.5.2.2 Saudi Arabia Natriuretic Peptide Market by End users/Applications
9.4.5.3 U.A.E Natriuretic Peptide Market
9.4.5.3.1 U.A.E Natriuretic Peptide Market by Product Type
9.4.5.3.2 U.A.E Natriuretic Peptide Market by End users/Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Natriuretic Peptide Market Overview
9.5.2 South and Central America Natriuretic Peptide Market Forecasts and Analysis
9.5.3 South and Central America Natriuretic Peptide Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Natriuretic Peptide Market Forecasts and Analysis - By End users/Applications
9.5.5 South and Central America Natriuretic Peptide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Natriuretic Peptide Market
9.5.5.1.1 Brazil Natriuretic Peptide Market by Product Type
9.5.5.1.2 Brazil Natriuretic Peptide Market by End users/Applications
9.5.5.2 Argentina Natriuretic Peptide Market
9.5.5.2.1 Argentina Natriuretic Peptide Market by Product Type
9.5.5.2.2 Argentina Natriuretic Peptide Market by End users/Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NATRIURETIC PEPTIDE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NATRIURETIC PEPTIDE MARKET, KEY COMPANY PROFILES
12.1. ABBOTT DIAGNOSTICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASSAYPRO
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AVIVA SYSTEMS BIOLOGY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BECKMAN COULTER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOMATIK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVUS BIOLOGICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RAYBIOTECH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ROCHE DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WEBMD LLC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Diagnostics
2. AssayPro
3. Aviva Systems Biology
4. Beckman Coulter Inc.
5. Biomatik
6. Bio-Rad Laboratories, Inc.
7. Novus Biologicals
8. Raybiotech
9. Roche Diagnostics
10. WebMD LLC.
TIPRE00011114
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking